Cullinan Oncology Inc.

NASDAQ: CGEM · Real-Time Price · USD
7.67
0.09 (1.19%)
At close: Aug 15, 2025, 3:59 PM
7.66
-0.07%
After-hours: Aug 15, 2025, 04:10 PM EDT

Cullinan Oncology Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-70.06M -48.5M -47.65M -40.56M -42.03M -37.15M -23.8M -39.18M -32.21M -58.14M -27.09M -24.89M 174.06M -12.89M -34.21M -18.26M -16.44M 1.42M
Depreciation & Amortization
77K 76K 77K 76K 77K 76K 77K 80K 81K 72K 59K 9K 12K 13K 12K 13K 13K 15K
Stock-Based Compensation
9.89M 9.37M 9.63M 9.43M 10.53M 8.23M 7.52M 7.74M 7.92M 7.26M 7.51M 5.27M 8.61M 6.57M 12.14M 4.56M 4.17M 3.51M
Other Working Capital
5.13M -3.51M 5.25M 1.28M 1M -7.12M 1.77M 1.36M -5.11M 630K -6.16M -33.33M 51.28M -109K 4.61M 1.7M -2.45M -2.56M
Other Non-Cash Items
-1.71M -2.31M -3.51M -4.93M -3.73M -3.5M 897K -3.2M -3.25M -1.37M -20.02M 171K -256.18M 946K -66.07M 17K 82K 1.72M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -6.13M 607K 1.1M n/a 19.57M n/a n/a -19.57M 67.19M 909K 803K -1.49M
Change in Working Capital
4.19M -1.79M 4.82M 1.84M -1.15M -5.9M 3.31M -181K -4.65M 1.18M -5.01M -34.91M 48.07M 3.03M 5.75M 2.21M -4.82M -6.69M
Operating Cash Flow
-57.61M -43.16M -36.63M -34.14M -36.29M -38.25M -18.13M -34.14M -31.01M -51M -24.98M -54.35M -25.42M -21.91M -15.17M -10.55M -16.2M -1.51M
Capital Expenditures
n/a n/a n/a n/a n/a n/a n/a n/a -49K -159K -882K -251K n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a -12.16K -15.34K -5M 5M n/a n/a n/a n/a 923K n/a
Purchase of Investments
-78.53M -125.84M -168.04M -96.8M -324.93M -131.37M -66.01M -136.78M -81.45M -89.14M -160.42M -124.13M -36.35M -57.02M -77.26M -85.3M -213.49M -149.76M
Sales Maturities Of Investments
131.93M 162.65M 184M 116.67M 139.82M 144.32M 117.48M 93.82M 93.61M 104.48M 132.6M 61.4M 67.2M 91.73M 61.4M 59.71M 58.9M 12.04M
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a 12.16K 15.34K 5.09M 5M 270M 34.71M -15.86M -25.59M -154.59M -137.73M
Investing Cash Flow
53.4M 36.8M 15.96M 19.88M -185.11M 12.96M 51.47M -42.96M 12.11M 15.18M -28.61M -57.98M 300.85M 34.71M -15.86M -25.59M -154.59M -137.73M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.82M -2.2M n/a n/a 800K n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a -656K -3.79M n/a n/a -178K 38.6M -36K -30.71M 1.43M 2.01M 2.74M 2.7M 579K 923K -2.69M
Financial Cash Flow
373K n/a 1.58M 1.32M 262.2M 1.08M 248K 112K 38.6M 1.79M -32.91M 1.43M 2.01M 3.54M 2.7M 579K 923K 264.58M
Net Cash Flow
-3.83M -6.35M -19.08M -12.94M 40.79M -24.21M 33.59M -76.99M 19.71M -34.02M -86.5M -110.91M 277.44M 16.34M -28.33M -35.56M -169.87M 125.34M
Free Cash Flow
-57.61M -43.16M -36.63M -34.14M -36.29M -38.25M -18.13M -34.14M -31.05M -51.16M -25.86M -54.6M -25.42M -21.91M -15.17M -10.55M -16.2M -1.51M